The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Hypoxia-Induced Inhibition of Adenosine Kinase Potentiates Cardiac Adenosine Release
Abstract
Abstract To elucidate the physiological role of the AMP-adenosine metabolic cycle and to investigate the relation between AMP and adenosine formation, the O 2 supply of isolated guinea pig hearts was varied (95% to 10% O 2 ). The net adenosine formation rate (AMP→adenosine) and coronary venous effluent adenosine release rate were measured; free cytosolic AMP was determined by 31 P-nuclear magnetic resonance. Switching from 95% to 40% O 2 increased free AMP and adenosine formation 4-fold, whereas free cytosolic adenosine and venous adenosine release rose 15- to 20-fold. In the AMP range from 200 to 3000 nmol/L, there was a linear correlation between free AMP and adenosine formation ( R 2 =.71); however, adenosine release increased several-fold more than formation. At 95% O 2 , only 6% of the adenosine formed was released; however, this fraction increased to 22% at 40% O 2 , demonstrating reduced adenosine salvage. Selective blockade of adenosine deaminase and adenosine kinase indicated that flux through adenosine kinase decreased from 85% to 35% of adenosine formation in hypoxia. Mathematical model analysis indicated that this apparent decrease in enzyme activity was not due to saturation but to the inhibition of adenosine kinase activity to 6% of the basal levels. The data show (1) that adenosine formation is proportional to the AMP substrate concentration and (2) that hypoxia decreases adenosine kinase activity, thereby shunting myocardial adenosine from the salvage pathway to venous release. In conclusion, because of the normal high turnover of the AMP-adenosine metabolic cycle, hypoxia-induced inhibition of adenosine kinase causes the amplification of small changes in free AMP into a major rise in adenosine. This mechanism plays an important role in the high sensitivity of the cardiac adenosine system to impaired oxygenation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arch, J. R. S., & Newsholme, E. A. (1978) · Biochemical Journal · doi:10.1042/bj1740965 · Cited by 273
Borst, M. M., & Schrader, J. (1991) · Circulation Research · doi:10.1161/01.res.68.3.797 · Cited by 162
Self-citationPak, M., Haas, H. L., Decking, U. K. M., & Schrader, J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90142-2 · Cited by 145
Self-citationEvidence for a substrate cycle between AMP and adenosine in isolated hepatocytes.
Bontemps, F., den Berghe, G. V., & Hers, H. G. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.10.2829 · Cited by 125
Human placental adenosine kinase. Kinetic mechanism and inhibition.
Palella, T. D., Andres, C. M., & Fox, I. H. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70780-7 · Cited by 114
Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart.
Kroll, K., Decking, U. K. M., Dreikorn, K., & Schrader, J. (1993) · Circulation Research · doi:10.1161/01.res.73.5.846 · Cited by 106
Self-citationFormation of S-adenosylhomocysteine in the heart. I: An index of free intracellular adenosine.
Deußen, A., Borst, M. M., & Schrader, J. (1988) · Circulation Research · doi:10.1161/01.res.63.1.240 · Cited by 91
Self-citationAdenosine kinase from rabbit liver. I. Purification by affinity chromatography and properties
Miller, R. L., Adamczyk, D. L., & Miller, W. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30226-0 · Cited by 87
Contribution of S-adenosylhomocysteine to cardiac adenosine formation
Deußen, A. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90716-5 · Cited by 85
Deußen, A., Borst, M. M., Kroll, K., & Schrader, J. (1988) · Circulation Research · doi:10.1161/01.res.63.1.250 · Cited by 77
Self-citation
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
The Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Carmeliet, E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.3.917 · Cited by 723
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
CNS energy metabolism as related to function
Ames, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00038-2 · Cited by 663
Cunha, R. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00034-6 · Cited by 631
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Schreiber, T. H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1260 · Cited by 600
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
Vallon, V., Mühlbauer, B., & Osswald, H. (2006) · Physiological Reviews · doi:10.1152/physrev.00031.2005 · Cited by 448
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 420
HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
Eltzschig, H. K., Abdulla, P., Hoffman, E., Hamilton, K. E., Daniels, D., Schönfeld, C., Löffler, M., Reyes, G., Duszenko, M., Karhausen, J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050177 · Cited by 351
Nucleoside transporters: molecular biology and implications for therapeutic development
Baldwin, S. A., Mackey, J. R., Cass, C. E., & Young, J. D. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01459-8 · Cited by 349
HIF‐dependent induction of adenosine A2B receptor in hypoxia
Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., & Colgan, S. P. (2006) · The FASEB Journal · doi:10.1096/fj.06-6419com · Cited by 335
Adenosine, adenosine receptors and myocardial protection An updated overview
Mubagwa, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00358-3 · Cited by 312
Adenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 310
Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction
Hofmann, U., & Frantz, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.304072 · Cited by 296
Immunosuppressive Activities of Adenosine in Cancer
Allard, B., Beavis, P. A., Darcy, P. K., & Stagg, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.04.001 · Cited by 292
Thiel, M., Chouker, A., Ohta, A., Jackson, E., Caldwell, C., Smith, P., Lukashev, D., Bittmann, I., & Sitkovsky, M. V. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030174 · Cited by 287
Tumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
The 5′-nucleotidases as regulators of nucleotide and drug metabolism
Hunsucker, S. A., Mitchell, B. S., & Spychala, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.003 · Cited by 284
Adenosine receptors: G protein-mediated signalling and the role of accessory proteins
Klinger, M., Freissmuth, M., & Nanoff, C. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00235-2 · Cited by 269
The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors?
Sitkovsky, M. V., & Ohta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.004 · Cited by 265
Morabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., & Cronstein, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 259
Sitkovsky, M. V., Kjaergaard, J., Lukashev, D., & Ohta, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0229 · Cited by 253
Acute adenosinergic cardioprotection in ischemic-reperfused hearts.
Headrick, J. P., Hack, B., & Ashton, K. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2003 · Cited by 171
D-Ribose as a Supplement for Cardiac Energy Metabolism
Pauly, D. F., & Pepine, C. J. (2000) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1054/jcpt.2000.18011 · Cited by 94
Leone, R. D., Horton, M. R., & Powell, J. D. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.014 · Cited by 42
Metadata
- Authors
- Decking, U. K. M., Schlieper, G., Kroll, K., & Schrader, J.
- Venue
- Circulation Research
- Published
- 1997-08
- Volume
- 81
- Issue
- 2
- Pages
- 154-164
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2036205982
- Cited by
- 265
- References
- 26
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.